Auerbach Hematology Oncology Associates P C
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Auerbach Hematology Oncology Associates P C sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Auerbach Hematology Oncology Associates P C: 5 sponsored US clinical trials, 1 recruiting.
Auerbach Hematology Oncology Associates P C sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Iron Deficiency Anemia, with 2 trials.
Upper-quartile sponsor footprint
Auerbach Hematology Oncology Associates P C sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
NCT04268849
Iron Parameters in Non-anemic First Trimester Gravidas
NCT03670537
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
NCT02499354
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
NCT02038023
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Auerbach Hematology Oncology Associates P C pipeline
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Iron Deficiency Anemia (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Auerbach Hematology Oncology Associates P C: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Auerbach Hematology Oncology Associates P C sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Auerbach Hematology Oncology Associates P C page
5 registered trials is a research-attention snapshot, not an endorsement of Auerbach Hematology Oncology Associates P C or any single study.
- 1 of Auerbach Hematology Oncology Associates P C's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Iron Deficiency Anemia is the condition Auerbach Hematology Oncology Associates P C studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Iron Deficiency Anemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Auerbach Hematology Oncology Associates P C pipeline card: 5 registered trials from official public datasets.Report a data error.